Zander Therapeutics, Inc — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2019)

$308.5K

Total Assets (FY2019)

$2.7M

Total Equity (FY2019)

$768.1K

Cash Flows from Operating Activities (FY2019)

-$1.2M

Source: Zander Therapeutics, Inc 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.